Developing the next generation of complement medicines
UK
Joined February 2022
- Tweets84
- Following2
- Followers193
- Likes63
Bright lights, big milestone. β¨
CTx001 is officially headed into the clinic!
@ComplementTx celebrates FDA IND clearance in the heart of Times Square β lighting up the @Nasdaq tower for the second time. π§¬π
π° Media coverage roundup β¬οΈ
#INDClearance #GeneTherapy #BiotechNews
Complement Therapeutics retweeted
ππ¨π¦π©ππ§π² πππ°π¬: @ComplementTx received IND clearance from U.S. FDA today to start a trial of its AAV gene therapy for geographic atrophy that delivers a truncated version of Complement Receptor 1 to the eye.
Full video: biotechtv.com/post/complemenβ¦
CTx001 is designed to modulate both classical and alternative complement pathways using a truncated CR1 (mini-CR1), delivered through AAV. A potentially durable, one-time treatment for GA, and this is just the start.
#Biotech #AMD #GeneTherapy #GeographicAtrophy #ClinicalTrial
π Big milestone for @ComplementTx:
Weβve received FDA IND clearance for CTx001, our lead gene therapy for Geographic Atrophy (GA).
Weβre now entering the clinic with Opti-GAIN, a first-in-human Phase I/II trial.
A huge step for the team, and for patients.
#INDClearance #CTx001
